The pharmaceutical industry’s battle over 340B drug discounts has extended to the states, as the Pharmaceutical Research and Manufacturers of America is challenging a Louisiana law that it says would effectively add contract pharmacies to the entities receiving 340B discounts.
Under the 340B Drug Pricing Program, drug manufacturers are required to provide significant price discounts to 15 statutorily specified types...






